Elon Musk, the billionaire founder of Neuralink, announced that the first human implant of the company’s brain-computer interface (BCI) device took place on Sunday, and the patient is currently recovering. The initial results of the implantation are promising, showing neuron spike detection.
Neuralink’s first human clinical trial, known as the PRIME Study (Precise Robotically Implanted Brain-Computer Interface), aims to evaluate the safety and functionality of the N1 implant, which is designed to enable people with quadriplegia to control devices with their thoughts.
The N1 implant is cosmetically invisible once placed and uses 1,024 electrodes distributed across 64 threads, each thinner than a human hair, to record and transmit brain signals wirelessly to an app that decodes them . The implant is surgically placed into a part of the brain that controls movement by a robot called the R1 Robot. The study is being conducted under the investigational device exemption (IDE) awarded by the U.S. Food and Drug Administration (FDA).
Neuralink’s BCI technology is intended to help people with paralysis control technology devices such as computer cursors or keyboards and may have the potential to restore full body movement and other functions in the future.
Also Read: EPACK Durable: India’s No. 2 AC Maker’s IPO Success
FAQ RELATED QUESTIONS
Q. Does Elon Musk own Neuralink?
Ans. Elon Musk has announced his brain chip company, Neuralink, has completed its first implant on a human patient.
Q. Who is the CEO of Neuralink?
Ans. Jared Birchall
Q. How much will Neuralink cost?
Ans. $10,500 (around £8,300)
Q. What is SpaceX for?
Ans. Designs and builds its reusable rockets and spacecraft
Q. Can I buy Neuralink?
Ans. Retail investors can’t buy a share of Neuralink because it isn’t a public company
I am Atul Sharma, As a full-time blogger, my focus is on delivering news articles on this platform. Your visit to my blog is highly appreciated. Thank you!